Of interest, we found that breast cancer patients demonstrated higher circulating level of ET-1 compared with the control cohorts, suggesting that ET-1 may contribute to a relative LVH in breast cancer patients (Fig. 4a). The gene discussed is EDN1; the disease is breast cancer.